History of the rare cancer network and past research

René Olivier Mirimanoff, Mahmut Ozsahin, Juliette Thariat, Enis Ozyar, Ulrike Schick, Berrin Pehlivan, Marco Krengli, Alessandra Franzetti Pellanda, Hansjörg Vees, Ling Cai, Luciano Scandolaro, Yazid Belkacemi, Salvador Villà, Sefik Igdem, Myroslav Lutsyk, Robert C. Miller

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Approximately, twenty years ago, the Rare Cancer Network (RCN) was formed in Lausanne, Switzerland, to support the study of rare malignancies. The RCN has grown over the years and now includes 130 investigators from twenty-four nations on six continents. The network held its first international symposium in Nice, France, on March 21-22, 2014. The proceedings of that meeting are presented in two companion papers. This manuscript reviews the history of the growth of the RCN and contains the abstracts of fourteen oral presentations made at the meeting of prior RCN studies. From 1993 to 2014, 74 RCN studies have been initiated, of which 54 were completed, 10 are in progress or under analysis, and 9 were stopped due to poor accrual. Forty-four peer reviewed publications have been written on behalf of the RCN.

Original languageEnglish (US)
Article number5462
Pages (from-to)86-90
Number of pages5
JournalRare Tumors
Volume6
Issue number3
DOIs
StatePublished - Aug 6 2014

Fingerprint

Research
Neoplasms
Switzerland
France
Publications
History
Research Personnel
Growth

Keywords

  • Cancer
  • Carcinoma
  • Diseases
  • Rare
  • Rare cancer network

ASJC Scopus subject areas

  • Oncology
  • Histology

Cite this

Mirimanoff, R. O., Ozsahin, M., Thariat, J., Ozyar, E., Schick, U., Pehlivan, B., ... Miller, R. C. (2014). History of the rare cancer network and past research. Rare Tumors, 6(3), 86-90. [5462]. https://doi.org/10.4081/rt.2014.5462

History of the rare cancer network and past research. / Mirimanoff, René Olivier; Ozsahin, Mahmut; Thariat, Juliette; Ozyar, Enis; Schick, Ulrike; Pehlivan, Berrin; Krengli, Marco; Pellanda, Alessandra Franzetti; Vees, Hansjörg; Cai, Ling; Scandolaro, Luciano; Belkacemi, Yazid; Villà, Salvador; Igdem, Sefik; Lutsyk, Myroslav; Miller, Robert C.

In: Rare Tumors, Vol. 6, No. 3, 5462, 06.08.2014, p. 86-90.

Research output: Contribution to journalArticle

Mirimanoff, RO, Ozsahin, M, Thariat, J, Ozyar, E, Schick, U, Pehlivan, B, Krengli, M, Pellanda, AF, Vees, H, Cai, L, Scandolaro, L, Belkacemi, Y, Villà, S, Igdem, S, Lutsyk, M & Miller, RC 2014, 'History of the rare cancer network and past research', Rare Tumors, vol. 6, no. 3, 5462, pp. 86-90. https://doi.org/10.4081/rt.2014.5462
Mirimanoff RO, Ozsahin M, Thariat J, Ozyar E, Schick U, Pehlivan B et al. History of the rare cancer network and past research. Rare Tumors. 2014 Aug 6;6(3):86-90. 5462. https://doi.org/10.4081/rt.2014.5462
Mirimanoff, René Olivier ; Ozsahin, Mahmut ; Thariat, Juliette ; Ozyar, Enis ; Schick, Ulrike ; Pehlivan, Berrin ; Krengli, Marco ; Pellanda, Alessandra Franzetti ; Vees, Hansjörg ; Cai, Ling ; Scandolaro, Luciano ; Belkacemi, Yazid ; Villà, Salvador ; Igdem, Sefik ; Lutsyk, Myroslav ; Miller, Robert C. / History of the rare cancer network and past research. In: Rare Tumors. 2014 ; Vol. 6, No. 3. pp. 86-90.
@article{310bfd89f28246b895a0ba2b9f1cd240,
title = "History of the rare cancer network and past research",
abstract = "Approximately, twenty years ago, the Rare Cancer Network (RCN) was formed in Lausanne, Switzerland, to support the study of rare malignancies. The RCN has grown over the years and now includes 130 investigators from twenty-four nations on six continents. The network held its first international symposium in Nice, France, on March 21-22, 2014. The proceedings of that meeting are presented in two companion papers. This manuscript reviews the history of the growth of the RCN and contains the abstracts of fourteen oral presentations made at the meeting of prior RCN studies. From 1993 to 2014, 74 RCN studies have been initiated, of which 54 were completed, 10 are in progress or under analysis, and 9 were stopped due to poor accrual. Forty-four peer reviewed publications have been written on behalf of the RCN.",
keywords = "Cancer, Carcinoma, Diseases, Rare, Rare cancer network",
author = "Mirimanoff, {Ren{\'e} Olivier} and Mahmut Ozsahin and Juliette Thariat and Enis Ozyar and Ulrike Schick and Berrin Pehlivan and Marco Krengli and Pellanda, {Alessandra Franzetti} and Hansj{\"o}rg Vees and Ling Cai and Luciano Scandolaro and Yazid Belkacemi and Salvador Vill{\`a} and Sefik Igdem and Myroslav Lutsyk and Miller, {Robert C.}",
year = "2014",
month = "8",
day = "6",
doi = "10.4081/rt.2014.5462",
language = "English (US)",
volume = "6",
pages = "86--90",
journal = "Rare Tumors",
issn = "2036-3605",
publisher = "PagePress",
number = "3",

}

TY - JOUR

T1 - History of the rare cancer network and past research

AU - Mirimanoff, René Olivier

AU - Ozsahin, Mahmut

AU - Thariat, Juliette

AU - Ozyar, Enis

AU - Schick, Ulrike

AU - Pehlivan, Berrin

AU - Krengli, Marco

AU - Pellanda, Alessandra Franzetti

AU - Vees, Hansjörg

AU - Cai, Ling

AU - Scandolaro, Luciano

AU - Belkacemi, Yazid

AU - Villà, Salvador

AU - Igdem, Sefik

AU - Lutsyk, Myroslav

AU - Miller, Robert C.

PY - 2014/8/6

Y1 - 2014/8/6

N2 - Approximately, twenty years ago, the Rare Cancer Network (RCN) was formed in Lausanne, Switzerland, to support the study of rare malignancies. The RCN has grown over the years and now includes 130 investigators from twenty-four nations on six continents. The network held its first international symposium in Nice, France, on March 21-22, 2014. The proceedings of that meeting are presented in two companion papers. This manuscript reviews the history of the growth of the RCN and contains the abstracts of fourteen oral presentations made at the meeting of prior RCN studies. From 1993 to 2014, 74 RCN studies have been initiated, of which 54 were completed, 10 are in progress or under analysis, and 9 were stopped due to poor accrual. Forty-four peer reviewed publications have been written on behalf of the RCN.

AB - Approximately, twenty years ago, the Rare Cancer Network (RCN) was formed in Lausanne, Switzerland, to support the study of rare malignancies. The RCN has grown over the years and now includes 130 investigators from twenty-four nations on six continents. The network held its first international symposium in Nice, France, on March 21-22, 2014. The proceedings of that meeting are presented in two companion papers. This manuscript reviews the history of the growth of the RCN and contains the abstracts of fourteen oral presentations made at the meeting of prior RCN studies. From 1993 to 2014, 74 RCN studies have been initiated, of which 54 were completed, 10 are in progress or under analysis, and 9 were stopped due to poor accrual. Forty-four peer reviewed publications have been written on behalf of the RCN.

KW - Cancer

KW - Carcinoma

KW - Diseases

KW - Rare

KW - Rare cancer network

UR - http://www.scopus.com/inward/record.url?scp=84905721677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905721677&partnerID=8YFLogxK

U2 - 10.4081/rt.2014.5462

DO - 10.4081/rt.2014.5462

M3 - Article

VL - 6

SP - 86

EP - 90

JO - Rare Tumors

JF - Rare Tumors

SN - 2036-3605

IS - 3

M1 - 5462

ER -